Literature DB >> 18834863

Spinophilin inhibits the binding of RGS8 to M1-mAChR but enhances the regulatory function of RGS8.

Seiji Fujii1, Ginko Yamazoe, Masayuki Itoh, Yoshihiro Kubo, Osamu Saitoh.   

Abstract

We showed previously that RGS8 directly binds to the third intracellular loop (i3L) of the M1 muscarinic acetylcholine receptor using the sequence MPRR at the N-terminus of RGS8 and specifically inhibits signal transduction. Here, we identified spinophilin (SPL) as an RGS8-interacting protein. We found that the SPL-binding site of RGS8 is the MPRR sequence, and the M1 receptor and SPL compete for binding to RGS8. However, we also observed that the expression of SPL significantly enhances the inhibitory function of RGS8, and that SPL can bind to the M1 receptor, demonstrating the indirect binding of RGS8 to the M1 receptor through SPL for an efficient regulatory function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18834863     DOI: 10.1016/j.bbrc.2008.09.096

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  RNA interference screen for RGS protein specificity at muscarinic and protease-activated receptors reveals bidirectional modulation of signaling.

Authors:  Geneviève Laroche; Patrick M Giguère; Bryan L Roth; Joann Trejo; David P Siderovski
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-23       Impact factor: 4.249

Review 2.  Regulating thrombus growth and stability to achieve an optimal response to injury.

Authors:  L F Brass; K M Wannemacher; P Ma; T J Stalker
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

3.  SIPA1L1/SPAR1 Interacts with the Neurabin Family of Proteins and is Involved in GPCR Signaling.

Authors:  Ken Matsuura; Shizuka Kobayashi; Kohtarou Konno; Miwako Yamasaki; Takahiro Horiuchi; Takao Senda; Tomoatsu Hayashi; Kiyotoshi Satoh; Fumiko Arima-Yoshida; Kei Iwasaki; Lumi Negishi; Naomi Yasui-Shimizu; Kazuyoshi Kohu; Shigenori Kawahara; Yutaka Kirino; Tsutomu Nakamura; Masahiko Watanabe; Tadashi Yamamoto; Toshiya Manabe; Tetsu Akiyama
Journal:  J Neurosci       Date:  2022-02-04       Impact factor: 6.709

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.